Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase
III
clinical trial with a 28‐week extension
2015 ◽
Vol 17
(6)
◽
pp. 599-602
◽
Keyword(s):
2015 ◽
Vol 17
(5)
◽
pp. 511-515
◽
2019 ◽
2019 ◽
2019 ◽
Vol 21
(11)
◽
pp. 2496-2504
◽
2005 ◽
Vol 27
(4)
◽
pp. 441-450
◽
Keyword(s):
Keyword(s):
2019 ◽
2014 ◽
Vol 17
(2)
◽
pp. 136-144
◽
Keyword(s):